Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

BACKGROUND/PURPOSE: NGX-4010 (QUTENZA(™); NeurogesX Inc, San Mateo, CA), a capsaicin 8% dermal patch, is licensed in the European Union for the treatment of peripheral neuropathic pain (PNP) in nondiabetic adults and in the United States for the treatment of neuropathic pain associated with postherp...

Descripción completa

Detalles Bibliográficos
Autores principales: Peppin, John F, Majors, Kristine, Webster, Lynn R, Simpson, David M, Tobias, Jeffrey K, Vanhove, Geertrui F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255992/
https://www.ncbi.nlm.nih.gov/pubmed/22247621
http://dx.doi.org/10.2147/JPR.S22954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255992/
https://www.ncbi.nlm.nih.gov/pubmed/22247621
http://dx.doi.org/10.2147/JPR.S22954

Ejemplares similares